Top 5 Trends in Clinical Partnering and Outsourcing

  Clinical Outsourcing and Partnering is entering a new age of popularity and it looks set to prosper. A report by Transparency Market Research indicates that the outsourced research market is expected to be worth $65.03 billion by 2018. Since the 1980s, more and more pharma, biopharma and biotechs have turned to clinical outsourcing and partnering. As the agenda for …

pra, whitepaper, human, liability, clinical trials

Download whitepaper: Risk-Based Monitoring for Late-Phase Research

The growing consensus among clinical researchers and regulatory authorities is that risk-based monitoring (RBM) is more likely to ensure patient protection and overall study quality, and allows for monitoring that can be more effective than the traditional model of routine visits to all sites with 100% source data verification (SDV). A number of factors are leading to the paradigm shift …

Risk-based monitoring could significantly modernize and streamline clinical trials

TransCelerate BioPharma Inc, an independent non-profit organization focused on accelerating the research and development of new medicines, has released a paper that outlines a standard approach for risk-based monitoring that can be adopted to any clinical trial, regardless of type, phase and stage (Press Release). The approach is designed to enhance patient safety and ensure quality clinical data, and could …